Alaunos Therapeutics reported $2K in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Amgen USD 10.4B 300M Sep/2026
AstraZeneca USD 16.21B 830M Sep/2026
Baxter International USD 2.98B 20M Sep/2026
Biogen USD 2.8B 60M Sep/2026
Bioline Rx USD 294K 183K Jun/2026
Bristol-Myers Squibb USD 13.07B 100M Sep/2026
Celltrion KRW 1.24T 90B Jun/2026
Corcept Therapeutics USD 340.5M 84.35M Sep/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Curis USD 1.14M 1.41M Dec/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 761K 298K Jun/2026
Divis Laboratories Ltd INR 36.76B 9.18B Sep/2026
Gilead Sciences USD 8.3B 500M Sep/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
Incyte USD 1.56B 110M Sep/2026
Intrexon USD 717K 511K Jun/2024
Ionis Pharmaceuticals USD 243M 25M Sep/2026
J&J USD 25.4B 89M Sep/2026
Kangmei Pharma CNY 1.19B 106M Jun/2026
Karyopharm Therapeutics USD 35.07M 987K Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Merck USD 18.1B 1.5B Sep/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Novartis USD 14.52B 112M Sep/2026
Organigram Holdings CAD 105.78M 45.99M Jun/2026
Pfizer USD 16.6B 1.57B Sep/2026
Pharma Mar EUR 54.2M 4.2M Sep/2026
PTC Therapeutics USD 357.8M 3.2M Sep/2026
Qiagen NV USD 487.78M 24.66M Sep/2026
Regeneron Pharmaceuticals USD 5.12B 830M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sangamo BioSciences USD 356K 125K Jun/2024
Sartorius EUR 926.3M 14.5M Sep/2026
Sino Biopharmaceutical CNY 19.44B 5.18B Jun/2026
TG Therapeutics USD 259.94M 19.6M Sep/2026
Tilray USD 217.51M 74.75M Dec/2025
Verastem USD 18.67M 1.14M Mar/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.78B 50M Sep/2026